Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exploiting genomics to discover new antibiotics.

D McDevitt1, M Rosenberg

  • 1Antimicrobials and Host Defense CEDD, GlaxoSmithKline, Collegeville, PA 19426, USA. damien_mcdevitt-1@gsk.com

Trends in Microbiology
|December 1, 2001
PubMed
Summary

The urgent need for new antibiotics drives the discovery of novel molecular targets through genomics and advanced technologies. This approach is yielding promising antibiotic leads for future development against resistant bacterial pathogens.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel targets for the future development of antibacterial agents.

Symposium series (Society for Applied Microbiology)·2002
Same author

Novel targets for the future development of antibacterial agents.

Journal of applied microbiology·2002
Same author

Regulated ectopic expression and allelic-replacement mutagenesis as a method for gene essentiality testing in Staphylococcus aureus.

Plasmid·2001
Same author

The srhSR gene pair from Staphylococcus aureus: genomic and proteomic approaches to the identification and characterization of gene function.

Biochemistry·2001
Same author

A functional genomic analysis of type 3 Streptococcus pneumoniae virulence.

Molecular microbiology·2001
Same author

Regulated gene expression in Staphylococcus aureus for identifying conditional lethal phenotypes and antibiotic mode of action.

Gene·2000

Area of Science:

  • Microbiology and Infectious Diseases
  • Genomics and Bioinformatics
  • Drug Discovery and Development

Background:

  • Rising antibiotic resistance in common bacterial pathogens necessitates the development of novel antibiotic classes.
  • Genomic information and advanced technologies are crucial for identifying and validating new antibacterial targets.
  • Existing antibiotic development strategies require innovation to address the growing threat of antimicrobial resistance.

Purpose of the Study:

  • To explore the strategy of identifying and exploiting new molecular targets for antibiotic development.
  • To highlight the role of genomics and new technologies in validating antibacterial targets.
  • To discuss the emergence of novel antibiotic leads from genomics-derived screens and the path to their optimization.

Main Methods:

Related Experiment Videos

  • Leveraging genomic sequence information to identify novel molecular targets.
  • Utilizing new technologies for rapid gene essentiality determination and transcriptional analysis during infection.
  • Implementing high-throughput screening against diverse compound collections for validated targets.

Main Results:

  • Identification of numerous novel and validated antibacterial targets.
  • Successful execution of high-throughput screens against diverse compound libraries.
  • Emergence of novel antibiotic leads from genomics-driven targeted screening efforts.

Conclusions:

  • Genomics and advanced validation technologies are effective in discovering novel antibacterial targets.
  • The identified antibiotic leads represent a promising starting point for the next generation of antibiotics.
  • Optimization and development of these leads are critical next steps in combating antibiotic resistance.